Spectral speech features may serve as noninvasive biomarkers for monitoring attention and executive function in major depressive disorder.

Explore therapeutic choices for patients with treatment-resistant depression, including ketamine, psilocybin, and various ...

Major depressive disorder (MDD) is a debilitating psychiatric condition characterized by a persistently low mood, a lack of ...

Biohaven said on Wednesday its experimental depression drug did not meet the main goal of a mid-stage trial, adding to a string of trial and regulatory setbacks for the drugmaker this year.

Recent research indicates that bodily inflammation may disrupt the brain’s ability to process rewards and risks in American Indian adults who have experienced depression. The study found that higher ...

DENVER, CO / / December 18, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous ...

Xenon Pharmaceuticals (XENE) is undervalued given azetukalner's late-stage potential to transform epilepsy and mood disorder ...

The FDA recently had a meeting to explore regulatory aspects of AI-enabled mental health medical devices. I explore a useful ...

During the pre-dawn hours in South Texas on Friday morning, SpaceX’s next-generation Starship first stage suffered some sort of major damage during pre-launch testing. The company had only rolled the ...

Please provide your email address to receive an email when new articles are posted on . Caplyta had been previously approved by FDA for bipolar I and II depression and schizophrenia. Approval was ...

Johnson & Johnson’s decision to splash out $14.6 billion on its purchase of Intra-Cellular Therapies earlier this year was largely driven by the acquired company's rising antipsychotic star Caplyta ...

Remission (MADRS total score ≤10) was seen in 65% of patients treated with lumateperone in combination with an oral antidepressant, at 6 months. The Food and Drug Administration (FDA) has approved ...